Skip to main content
SpringerLink
Log in

Applications in Head and Neck Cancer

  • Chapter
Multimodal Concepts for Integration of Cytotoxic Drugs

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 570 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adelstein DJ, Li Y, Adams GL et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92–98

    Article  PubMed  Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317

    PubMed  CAS  Google Scholar 

  • American Cancer Society (2005) Cancer Facts and Figures 2005, available online under www.cancer.org/docroot/STT/stt_0.asp

    Google Scholar 

  • Andres L de, Brunet J, Lopez-Pousa A et al (1995) Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol 13:1493–1500

    PubMed  Google Scholar 

  • Antonadou D, Pepelassi M, Synodinou M et al (2002) Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer. Int J Radiat Oncol Biol Phys 52:739–747

    Article  PubMed  CAS  Google Scholar 

  • Bachaud JM, Cohen-Jonathan E, Alzieu C et al (1996) Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 36:999–1004

    Article  PubMed  CAS  Google Scholar 

  • Bernier J, Domenge C, Ozsahin M et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952

    Article  PubMed  CAS  Google Scholar 

  • Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27:843–850

    Article  PubMed  Google Scholar 

  • Bourhis J, Amand C, Pignon JP (2004) Update of MACH-NC (meta-analysis of chemotherapy in head and neck cancer) database focused on concomitant chemoradiotherapy (Abstract). J Clin Oncol 22:489s

    Google Scholar 

  • Brizel DM, Albers ME, Fisher SR et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798–1804

    Article  PubMed  CAS  Google Scholar 

  • Brizel DM, Wasserman TH, Henke M et al (2000) Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18:3339–3345

    PubMed  CAS  Google Scholar 

  • Buntzel J, Kuttner K, Frohlich D et al (1998) Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer. Ann Oncol 9:505–509

    Article  PubMed  CAS  Google Scholar 

  • Buntzel J, Glatzel M, Kuttner K et al (2002) Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer. Semin Radiat Oncol 12:4–13

    Article  PubMed  Google Scholar 

  • Calais G, Alfonsi M, Bardet E et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91:2081–2086

    Article  PubMed  CAS  Google Scholar 

  • Calais G, Alfonsi M, Bardet E et al (2000) Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy. Bull Cancer 87 (Spec no.):48–53

    PubMed  Google Scholar 

  • Chan AT, Teo PM, Leung TW et al (1995) A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33:569–577

    Article  PubMed  CAS  Google Scholar 

  • Cmelak AJ, Li S, Goldwasser M et al (2005) A phase II trial of chemoradiation (CR) for organ preservation in respectable stage III or IV squamous cell carcinomas of the larynx (L) or oropharynx (OP): a trial of the Eastern Cooperative Oncology Group (E2399). Abstract 5509, Proc Am Soc Clin Oncol, pp 5509

    Google Scholar 

  • Colevas AD, Norris CM, Tishler RB et al (1999) Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck. J Clin Oncol 17:3503–3511

    PubMed  CAS  Google Scholar 

  • Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944

    Article  PubMed  Google Scholar 

  • De Andres L, Brunet J, Lopez-Pousa A et al. (1995) Randomized trial of neoadjuvant cisplatin and fluorouracil versus carboplatin and fluorouracil in patients with stage IV-M0 head and neck cancer. J Clin Oncol 13:1493–1500

    PubMed  Google Scholar 

  • Denis F, Garaud P, Bardet E et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69–76

    Article  PubMed  Google Scholar 

  • Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685–1690

    Article  Google Scholar 

  • Dorr W, Reichel S, Spekl K (2005) Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother Oncol 75:99–105

    Article  PubMed  CAS  Google Scholar 

  • El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838–847

    PubMed  CAS  Google Scholar 

  • Fonseca E, Grau JJ, Sastre J et al (2005) Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. Eur J Cancer 41:1254–1260

    Article  PubMed  CAS  Google Scholar 

  • Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  PubMed  CAS  Google Scholar 

  • Garden AS, Harris J, Vokes EE et al (2004) Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 22:2856–2864

    Article  PubMed  CAS  Google Scholar 

  • Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720

    Article  PubMed  CAS  Google Scholar 

  • Gosselin TK, Raj KA, Clough RW et al (2005) Amifostine for Xerostomia: Normal tissue protection at what cost? Abstract 212, Proc Am Soc Ther Rad Oncol, Elsevier, pp S128

    Google Scholar 

  • Haddad RI, Tishler RB, Wirth L et al (2005) Rate of complete pathological responses (pCR) to docetaxel/cisplatin/5-fluorouracil (TPF) induction chemotherapy in patients with newly diagnosed, locally advanced squamous cell carcinoma of the head and neck (SCCHN). Abstract 5511, Proc Am Soc Clin Oncol

    Google Scholar 

  • Hitt R, Lopez-Pousa A, Rodriguez M et al (2003) Phase III study comparing cisplatin (P) and 5-fluoruracil (F) versus P, F and paclitaxel (T) as induction therapy in locally advanced head and neck cancer (LAHNC). Abstract 1997, Proc Am Soc Clin Oncol

    Google Scholar 

  • Hitt R, Grau J, Lopez-Pousa A et al (2005) Phase II/III trial of induction chemotherapy(ICT) with cisplatin/5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) followed by chemoradiotherapy (CRT) vs CRT for unresectable locally advanced head and neck cancer (LAHNC). Abstract 5578, Proc Am Soc Clin Oncol

    Google Scholar 

  • Holsti LR, Mantyla M (1988) Split-course versus continuous radiotherapy. Analysis of a randomized trial from 1964 to 1967. Acta Oncol 27:153–161

    PubMed  CAS  Google Scholar 

  • Johnson JT, Ferretti GA, Nethery WJ et al (1993) Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390–395

    Article  PubMed  CAS  Google Scholar 

  • Katori H, Tsukuda M, Ishitoya J et al (2005) Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation versus concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol, pp 5580

    Google Scholar 

  • Kish JA, Ensley J, Crissman J et al (1985) The role of induction chemotherapy in advanced head and neck cancer: the Wayne State University experience. Prog Clin Biol Res 201:177–189

    PubMed  CAS  Google Scholar 

  • Kwong DL, Sham JS, Au GK (2003) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. Proc Am Soc Clin Oncol 22:495

    Google Scholar 

  • Lee AW, Lau WH, Tung SY et al (2004) Prospective randomized study on therapeutic gain achieved by addition of chemotherapy for T1-4N2-3M0 nasopharyngeal carcinoma (NPC). Abstract 5506. Proc Am Soc Clin Oncol 22 No 14S:489s

    Google Scholar 

  • Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899

    PubMed  CAS  Google Scholar 

  • Munro AJ (1995) An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83–91

    PubMed  CAS  Google Scholar 

  • Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Metaanalysis of chemotherapy on head and neck cancer. Lancet 355:949–955

    PubMed  CAS  Google Scholar 

  • Posner MR (2001) Docetaxel in squamous cell cancer of the head and neck. Anticancer Drugs 12(Suppl 1):S21–S24

    PubMed  CAS  Google Scholar 

  • Posner MR, Glisson B, Frenette G et al (2001) Multicenter phase I-II trial of docetaxel, cisplatin, and fluorouracil induction chemotherapy for patients with locally advanced squamous cell cancer of the head and neck. J Clin Oncol 19:1096–1104

    PubMed  CAS  Google Scholar 

  • Psyrri A, Kwong M, DiStasio S et al (2004) Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol 22:3061–3069

    Article  PubMed  CAS  Google Scholar 

  • Rischin D, Peters L, Fisher R et al (2005) Tirapazamine, cisplatin and radiation versus fluorouracil, cisplatin and radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J Clin Oncol 23:79–87

    Article  PubMed  CAS  Google Scholar 

  • Rossi A, Molinari R, Boracchi P et al (1988) Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 6:1401–1410

    PubMed  CAS  Google Scholar 

  • Shin DM, Glisson BS, Khuri FR et al (2002) Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer 95:322–330

    Article  PubMed  CAS  Google Scholar 

  • Vermorken JB, Remenar E, van Herpen C et al (2004) Standard cisplatin/infusional 5-flourouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinioma of the head and neck (LA-SCHHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971). Abstract 5508, Proc Am Soc Clin Oncol

    Google Scholar 

  • Vokes EE, Mick R, Lester EP et al (1991) Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution. J Clin Oncol 9:1376–1384

    PubMed  CAS  Google Scholar 

  • Warde P, O’Sullivan B, Aslanidis J et al (2002) A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 54:9–13

    Article  PubMed  CAS  Google Scholar 

  • Wasserman TH, Brizel DM (2001a) The role of amifostine as a radioprotector. Oncology (Williston Park) 15:1349–1354; discussion 1357–1360

    PubMed  CAS  Google Scholar 

  • Wasserman TH, Brizel DM (2001b) Has the outlook improved for amifostine as a clinical radioprotector. Radiother Oncol 60:334–336

    Article  PubMed  CAS  Google Scholar 

  • Wasserman T, Mackowiak JI, Brizel DM et al (2000) Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys 48:1035–1039

    Article  PubMed  CAS  Google Scholar 

  • Wasserman TH, Brizel DM, Henke H et al (2005) Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63:985–990

    Article  PubMed  CAS  Google Scholar 

  • Wee J, Tan EH, Tai BC (2004) Phase III randomized trial of radiotherapy versus concurrent chemo-radiotherapy followed by adjuvant chemotherapy in patient with AJCC/UICC (1997). Stage 3 and 4 nasopharyngeal cancer of the endemic varitey. Proc Am Soc Clin Oncol 23:487

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Human Oncology, University of Wisconsin, 600 Highland Avenue, K4 312-3684, Madison, WI, 53792, USA

    Deepak Khuntia MD (Assistant Professor) & Paul M. Harari MD (Jack Fowler Professor)

  2. Department of Medicine, University of Wisconsin, 600 Highland Avenue, K4 312-3684, Madison, WI, 53792, USA

    Anne M. Traynor MD (Assistant Professor)

  3. Head of Radiation Oncology Department, Institute Gustave-Roussy, 39, rue Camille Desmoulins, 94805, Villejuif Cedex, France

    Jean Bourhis MD (Professor)

Authors
  1. Deepak Khuntia MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne M. Traynor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul M. Harari MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jean Bourhis MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Khuntia, D., Traynor, A.M., Harari, P.M., Bourhis, J. (2006). Applications in Head and Neck Cancer. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_13

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation